Human Pancreatic Islets

Cat.No.: CSC-C4882L

Species: Human

Source: Pancreatic Islet; Pancreas

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4882L
Description
Human Pancreatic Islets are isolated from the pancreas of human using Collagenase P and purified using Ficoll density gradient.
Species
Human
Source
Pancreatic Islet; Pancreas
Disease
Normal
Quality Control
Human Pancreatic Islets are tested for their viability using FDA/PI, purity using Dithizone staining, static insulin secretion in response to 14 mM glucose. Upon request, dynamic insulin secretion and calcium imaging in response to glucose and other stimulators can be performed.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use.
Never can cryopreserved cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human Pancreatic Islets are highly specialized 3-dimensional microorgans isolated from the pancreas of human donors. Instead of a single cell line, they are a heterogeneous population of endocrine cells, mostly insulin-producing β cells, glucagon-secreting α cells, somatostatin-producing δ cells, and pancreatic polypeptide (PP) cells. These cells collectively play a key role in the maintenance of glucose homeostasis through tightly regulated hormone secretion. Human pancreatic islets are one of the most valuable systems for the study of human Diabetes mellitus as they recapitulate closely native pancreatic endocrine function and are physiologically relevant ex vivo models. They are widely used in studies of glucose-stimulated insulin secretion (GSIS), beta-cell dysfunction, and islet transplantation biology. In contrast to immortalized β-cell lines, human islets preserve native cell-cell interactions and intrinsic signaling networks and are more translationally relevant for metabolic and pharmacological studies.

Furthermore, human pancreatic islets are important for the evaluation of drug-induced β-cell toxicity, screening of anti-diabetic compounds, and study of mechanisms of islet inflammation and immune-mediated damage. They are also a vital model in regenerative medicine and cell replacement therapy research. Despite limitations in human pancreatic islet availability and donor variability, they are the gold standard in vitro system for the study of human pancreatic endocrine physiology and diabetes pathophysiology.

Cytokine Treatment of Cultured Human Islets Upregulates MHC-I and MHC-II Antigen Presentation Pathways

Type 1 diabetes (T1D) involves T cell destruction of β-cells, potentially triggered by inflammatory epitopes. To characterize the human islet immunopeptidome, Nanaware et al. treated cadaveric non-diabetic islets with pro-inflammatory cytokines.

Cytokine treatment induced the loss of acinar cells and significantly upregulated MHC-II (HLA-DR) on insulin-positive and immune cells (Fig.1A-D; Fig. 2B). Bulk RNA-seq of sorted populations revealed the most pronounced transcriptional upregulation of MHC-I (NLRC5, HLA-A/B/C) and MHC-II (CIITA, HLA-DP/DQ) antigen presentation pathways in β-cells (Fig. 1E-H), corroborated by scRNA-seq (Fig. 2A).

Critically, genes upregulated by cytokine treatment overlapped significantly with those identified in β-cells from T1D donors versus controls (p < 0.001), validating the in vitro model against in vivo disease states. These data demonstrate that cytokine stimulation effectively simulates the T1D milieu by enhancing MHC expression and antigen presentation machinery in human islets.

Cytokine treatment of cultured human islets upregulates MHC-I and MHC-II antigen presentation pathways

Fig. 1. Cytokine treatment of cultured human islets upregulates MHC-I and MHC-II antigen presentation pathways (Nanaware P P, Caivo-Calle J M, et al., 2025).

Single-cell analysis of MHC-I and MHC-II expression before and after treatment with inflammatory cytokines

Fig. 2. Single-cell analysis of MHC-I and MHC-II expression before and after treatment with inflammatory cytokines (Nanaware P P, Caivo-Calle J M, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products